Pure Global
NCT05992181

Development of a Digital Tool for the Individualization of Speech Therapy Care for Premature Newborns

Centre Hospitalier Sud Francilien·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Premature Birth
Drug/Device/Intervention
NEORTHO
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Centre Hospitalier Sud Francilien
Location
Corbeil-Essonnes, France
Timeline & enrollment
Phase
N/A
Start date
Sep 15, 2023
End date
Jun 15, 2024
Enrollment
40 participants
Primary outcome

Milk taken daily

Summary

The study concerns the creation and implementation of a digital tool presenting the various
 orofacial stimuli that can be offered to premature newborns. This app is intended for
 parents, to allow them to play a more active role in their child's care, and provide them
 with special time with their child. The notion of pleasure is very important to us, and it's
 vital to help parents rediscover this feeling with their child. Different profiles will be
 created to individualize our recommendations, facilitate the understanding of orofacial
 stimuli, make them more concrete than drawings, and provide care adapted to each patient and
 improve the development of newborns through more regular orofacial stimulation.

ICD-10 classifications
Fetus and newborn affected by precipitate deliveryPreterm delivery without spontaneous labourDisorders related to short gestation and low birth weight, not elsewhere classifiedOther preterm infantsPreterm spontaneous labour with preterm delivery
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05992181
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05992181 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Sud Francilien and is currently Recruiting. The study focuses on Premature Birth. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.